These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 398355)

  • 1. [What has been achieved in the therapy of calcium nephrolithiasis?].
    Tschöpe W; Ritz E
    Internist (Berl); 1979 Dec; 20(12):599-606. PubMed ID: 398355
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate.
    Pak CY; Delea CS; Bartter FC
    N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metaphylaxis on the basis of outpatient metabolic tests in nephrolithiasis].
    Hiblbauer J; Base J; Zita K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(3):379-84. PubMed ID: 3206213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hydrochlorothiazide on calcium-magnesium parameters in patients with recurrent nephrolithiasis].
    Musialik D; Głuszek J; Raszeja-Wanic B
    Pol Tyg Lek; 1978 Jul; 33(30):1173-5. PubMed ID: 693386
    [No Abstract]   [Full Text] [Related]  

  • 6. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis.
    Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K
    Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The interrelationship between calcium and magnesium homeostasis and its significance for the relapse-prevention treatment of calcium nephrolithiasis].
    Tsachev K; Ivanov I
    Vutr Boles; 1990; 29(4):48-52. PubMed ID: 2281659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Calcium nephrolithiasis and cellulose phosphate.
    Williams HE
    N Engl J Med; 1974 Jan; 290(4):224-5. PubMed ID: 4808920
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
    Jacobellis U; Salerno G; Ruotolo G
    Arch Esp Urol; 1984 Dec; 37 Suppl 1():577-81. PubMed ID: 6100036
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide.
    Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():125-34. PubMed ID: 6937988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Active and recurrent kidney calculi. Metabolic findings and therapeutic consequences].
    Jorgensen H; Quist Paulsen A; Berstad A; Harbitz TB
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1551-5. PubMed ID: 929531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical aspects of conservative therapy of nephrolithiasis].
    Kallistratos G
    Med Welt; 1972 Jun; 23(23):843-51. PubMed ID: 5040887
    [No Abstract]   [Full Text] [Related]  

  • 13. [The significance of uric acid in calcium oxalate nephrolithiasis].
    Hartung R
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):387-90. PubMed ID: 804601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium, phosphorus and magnesium metabolism in patients with recurrent nephrolithiasis].
    Kwias Z; Twardosz W
    Pol Przegl Chir; 1976; 48(5):605-10. PubMed ID: 1272989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypercalciuria and kidney calculi].
    Netelenbos JC; Haagsma-Schouten WA; Lopes Cardozo E
    Ned Tijdschr Geneeskd; 1978 Dec; 122(51):2020-5. PubMed ID: 723991
    [No Abstract]   [Full Text] [Related]  

  • 16. Thiazides and calcium urolithiasis.
    Yendt ER; Cohanim M
    Can Med Assoc J; 1978 Apr; 118(7):755-8. PubMed ID: 638900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolic findings in patients with urate nephrolithiasis].
    Revúsová V; Gratzlová J; Valovicová E; Krídl J
    Vnitr Lek; 1973 Aug; 19(8):744-9. PubMed ID: 4731150
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone mineral content in idiopathic calcium nephrolithiasis.
    Barkin J; Wilson DR; Manuel MA; Bayley A; Murray T; Harrison J
    Miner Electrolyte Metab; 1985; 11(1):19-24. PubMed ID: 3974535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrolithiasis induced by hyperparathyroidism].
    Marković V; Macura D
    Srp Arh Celok Lek; 1974 Feb; 102(2):101-10. PubMed ID: 4410206
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria].
    Ivanov I; Tsachev K
    Vutr Boles; 1990; 29(3):64-8. PubMed ID: 2284802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.